tiprankstipranks
NobleOak Life Ltd (AU:NOL)
ASX:NOL
Australian Market
Want to see AU:NOL full AI Analyst Report?

NobleOak Life Ltd (NOL) AI Stock Analysis

8 Followers

Top Page

AU:NOL

NobleOak Life Ltd

(Sydney:NOL)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - Gpt-5.6Sol)
Rating:78Outperform
Price Target:
AU$1.50
â–²(15.38% Upside)
Action:Upgraded
Date:08/29/26
The score is driven primarily by strong financial performance (low leverage and strong recent cash generation) and an attractive valuation (low P/E). Technicals are supportive in the near term (above key shorter moving averages with moderately positive momentum) but are tempered by the price still being below the 200-day average and by historically variable profitability and thin margins.
Positive Factors
Very Low Financial Leverage
A conservatively capitalised balance sheet limits financial risk and gives NobleOak greater flexibility to absorb claims volatility, invest in distribution and support growth without relying heavily on external funding.
Negative Factors
Thin Net Profit Margins
A thin earnings margin leaves limited protection against adverse claims, pricing, lapse or expense movements. Even with revenue growth, relatively small changes in underwriting or operating performance could materially affect profit.
Read all positive and negative factors
Positive Factors
Negative Factors
Very Low Financial Leverage
A conservatively capitalised balance sheet limits financial risk and gives NobleOak greater flexibility to absorb claims volatility, invest in distribution and support growth without relying heavily on external funding.
Read all positive factors

NobleOak Life Ltd (NOL) vs. iShares MSCI Australia ETF (EWA)

NobleOak Life Ltd Business Overview & Revenue Model

Company Description
NobleOak Life Limited engages in underwriting life insurance products in Australia. It offers life, income protection, total and permanent disability, death, trauma, business expenses, and self-managed super fund insurance plans. The company sells...
How the Company Makes Money
NobleOak makes money primarily by underwriting and distributing life insurance policies and earning a margin between (a) the premiums it collects from policyholders and (b) the costs it incurs to provide that cover. Key revenue and earnings driver...

NobleOak Life Ltd Financial Statement Overview

Summary
Strong overall fundamentals supported by a very low-leverage balance sheet (debt-to-equity ~3.7%) and strong 2026 operating/free cash flow (~67M) with meaningful growth versus 2025. Offsetting this, profitability is thin and has been volatile (2026 net margin ~2.7%), making earnings more sensitive to underwriting/pricing and cost dynamics.
Income Statement
72
Positive
Balance Sheet
85
Very Positive
Cash Flow
78
Positive
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue527.86M123.99M386.65M343.40M75.43M
Gross Profit9.05M123.99M50.26M181.86M169.78M
EBITDA22.20M17.50M20.33M18.67M4.22M
Net Income14.11M7.12M9.28M7.99M1.69M
Balance Sheet
Total Assets655.55M567.29M463.73M251.15M121.08M
Cash, Cash Equivalents and Short-Term Investments79.81M85.55M63.96M30.26M30.26M
Total Debt3.81M4.58M5.26M5.83M556.00K
Total Liabilities552.02M478.36M392.33M131.31M9.45M
Stockholders Equity103.53M88.94M71.41M119.84M111.63M
Cash Flow
Free Cash Flow67.18M58.63M44.02M129.66M23.49M
Operating Cash Flow67.37M58.74M44.42M130.14M27.98M
Investing Cash Flow-72.00M-45.59M-29.86M-108.81M-53.33M
Financing Cash Flow-1.11M8.44M-1.01M-1.18M23.77M

NobleOak Life Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.30
Price Trends
50DMA
1.18
Positive
100DMA
1.22
Positive
200DMA
1.30
Positive
Market Momentum
MACD
0.03
Negative
RSI
62.38
Neutral
STOCH
78.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NOL, the sentiment is Positive. The current price of 1.3 is above the 20-day moving average (MA) of 1.17, above the 50-day MA of 1.18, and above the 200-day MA of 1.30, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 62.38 is Neutral, neither overbought nor oversold. The STOCH value of 78.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NOL.

NobleOak Life Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
AU$120.94M8.5614.18%―12.24%83.56%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
AU$3.80B37.325.61%3.16%5.84%-49.20%
65
Neutral
AU$6.02B50.2121.88%0.90%23.25%50.21%
63
Neutral
AU$6.76B12.1612.37%2.95%-24.88%193.04%
53
Neutral
AU$6.03B33.205.08%2.02%-4.68%4.33%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NOL
NobleOak Life Ltd
1.30
-0.31
-19.50%
AU:AMP
AMP
2.48
0.83
50.49%
AU:AUB
AUB Group
29.11
-4.67
-13.83%
AU:CGF
Challenger
9.97
1.85
22.81%
AU:HUB
HUB24 Limited
73.81
-27.97
-27.48%

NobleOak Life Ltd Corporate Events

NobleOak Files Updated Corporate Governance Statement with ASX
Aug 27, 2026
NobleOak Life Limited has lodged its updated corporate governance statement for the year ended 30 June 2026, making it available via its website in accordance with ASX Listing Rule requirements. The statement has been approved by the board and is ...
NobleOak Details 2026 Corporate Governance Framework
Aug 27, 2026
NobleOak Life Limited has released its 2026 Corporate Governance Statement, detailing its framework for board oversight, management accountability and ethical conduct. The document sets out how the insurer structures its board to add value, instil...
NobleOak Named ANZIIF Life Insurance Company of the Year 2026
Aug 27, 2026
NobleOak Life Ltd has been named Life Insurance Company of the Year for 2026 by ANZIIF, the leading professional association for the insurance and finance industry in the Asia-Pacific region. The award recognises excellence in customer service, in...
NobleOak Life posts strong FY26 profit growth and expands market share
Aug 27, 2026
NobleOak Life reported FY26 in‑force premiums of $549.2 million, up 18 percent, driven by nine percent growth in new business and lapse rates below industry averages. Market share across direct and advised channels rose to 4.7 percent, suppo...
NobleOak Life Delivers Strong FY26 Growth, Beats Guidance
Aug 27, 2026
NobleOak Life Limited reported a strong FY26 financial performance, with in‑force premiums rising 18% to $549.2 million, ahead of its guidance. New business premiums grew 9% to $69.2 million, while underlying NPAT increased 15% and reported ...
NobleOak Sets Date for FY26 Results and Investor Webcast
Aug 7, 2026
NobleOak Life Ltd, a long-established Australian life insurer known for its direct-to-consumer digital offerings and white-labelled products for distribution partners, continues to position itself in the market as a provider of accessible and comp...
NobleOak Discloses Final Director Interest Notice for Stephen Harrison
Jul 22, 2026
NobleOak Life Limited has disclosed the final director’s interest notice for Stephen James Harrison following his cessation as a director on 22 July 2026, in line with ASX listing rule 3.19A.3. The filing confirms his direct holding of 150,4...
NobleOak expects reduced exposure after securing Victorian stamp duty relief
Jul 5, 2026
NobleOak Life Limited, a long-established Australian life insurer, has evolved from its benevolent society roots into a modern provider of direct-to-consumer and white‑labelled life insurance products. Its strategy centres on delivering comp...
NobleOak lifts Embedded Value and hits FY26 in-force premium target
Jun 21, 2026
NobleOak Life Limited, an Australian direct life insurer with a long heritage, operates a digital-first, direct-to-consumer model complemented by white-labelled products for partners distributed via advisers. The company focuses on providing compe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 29, 2026